Leaderboard

En | De
Sie sind hier: Gynäkologie » Mammae 18. Mai 2026
Suchen
medline.ch
Mammae
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Fortpflanzung
Genitale Erkrankungen
Infertilität
Mammae
Menopause
Schwangerschaft
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 10886  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 217709  
   
Emerging trends in implication of nanocarriers in repolarization of tumor associated macrophages for improved triple negative breast cancer therapy.
Colloids Surf B Biointerfaces
Banjare N, Singh M, Kuiry A, Gupta PN.
PMID: 42143910 [PubMed - as supplied by publisher]


Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study.
J Inorg Biochem
Helal MA, Abdel-Mohsen MA, Toson EA.
PMID: 42143555 [PubMed - as supplied by publisher]


Latent profiles of parenting concerns and influencing factors among Chinese breast cancer mothers: a mixed-methods study.
Eur J Oncol Nurs
Zhang YH, Xu Q, Cao ZY, Ding M, Wang ZZ, Hong JF.
PMID: 42143437 [PubMed - as supplied by publisher]


Predictors of pathologic complete response in triple‑negative breast cancer treated with neoadjuvant chemotherapy: a systematic review and meta-analysis.
Clin Exp Med
Li X, Peng K, Li Q.
PMID: 42143190 [PubMed - as supplied by publisher]


Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model.
Sci Rep
Keshavarz F, Kouchaki A, Soltanshahi M, Jaafari MR, Mafi AR, Shabani M, Jalali SA.
PMID: 42143109 [PubMed - as supplied by publisher]


Betulinic acid is associated with miR-21 modulation, apoptosis and redox changes in breast cancer cells: an in vitro and in silico study.
Sci Rep
Mahmoud MA, Abdo H, Mekky M, Salem T, Mabrouk S, Khaled B.
PMID: 42143107 [PubMed - indexed for MEDLINE]


Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions.
Cancer Lett
Sabit H, Ghazy A, Albogami KFKM, Abdelhadi OE, Abdel-Ghany S, Arneth B.
PMID: 42142702 [PubMed - as supplied by publisher]


Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers: A prospective, phase II trial.
Radiother Oncol
Shaitelman SF, Krishnamurthy S, Lin H, Rauch GM, Shen Y, Valero V, Johnson HM, Muruganandham M, Smith BD, Hoffman KE, Lee BM, Shinn E, Symmans WF, Woodward WA, Mitchell MP, Goodman CR, Buzdar A, Singh P, Tamirisa N, Kuerer H, Division of Radiation Oncology Biomarker Strategic Initiative Laboratory Group, Exceptional Responders Study Group.
PMID: 42142534 [PubMed - as supplied by publisher]


"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?".
Eur J Cancer
Conforti F, Sala I, Pala L, Bendoni M, Canzian J, Tinterri B, De Pas T, Locatelli M, Bagnardi V, Gelber R.
PMID: 42142430 [PubMed - as supplied by publisher]


An exploratory study on exposure to bisphenol A analogues and breast cancer risk.
Environ Int
Siddique S, Habibagahi A, Marro L, Bouraoui I, Kubwabo C, Harris SA.
PMID: 42142421 [PubMed - as supplied by publisher]


Increasing efficiency in the ACR Digital Mammography QC Manual's DBT Z-resolution evaluation.
J Appl Clin Med Phys
Fisher RF, Bevins NB, Hulme KW, Schaeffer C.
PMID: 42142398 [PubMed - indexed for MEDLINE]


Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial.
Br J Surg
Ishitobi M, Tanaka K, Shimomura A, Yamanaka T, Tsukioki T, Iwata H, Hara F, Fujisawa T, Sasaki K, Kajikawa R, Sakai T, Sagara Y, Shigematsu H, Ozaki Y, Nozawa K, Sudo K, Naito Y, Terata K, Ishiba T, Fukuda H, Shien T.
PMID: 42142363 [PubMed - as supplied by publisher]


Meta-analytic estimates of Risk of Malignancy (ROM) of cytopathology reporting systems: Lacunae, limitations and a proposed solution with an example from the IAC Yokohama system for breast cytopathology.
Acta Cytol
Jandrasupalli KK, Singh M, Singh N, Rajaganesh S, Chowdhury N.
PMID: 42142344 [PubMed - as supplied by publisher]


Association of CA12 with calcification in ER+/HER-2 negative breast cancer.
Discov Oncol
Zhu Y, Du Q, Ma Y, Xu N, Luo Y, Liu D.
PMID: 42142233 [PubMed - as supplied by publisher]


Effects of yoga on depressive symptoms in breast cancer patients: a meta-analysis of randomized controlled trials.
Support Care Cancer
Li Y, Wang J, Wang Z, Yun J, Yang Y, Yang X, Xiao X, Ren C.
PMID: 42142147 [PubMed - indexed for MEDLINE]


Machine learning-driven integration of multi-omics data uncovers methylation-dependent molecular signatures for luminal A and B breast cancer subtypes.
Epigenomics
Elsisi M, Maged M, Elhwary M, Abdallah K, Alaa-Eldin H, K Elsherif A.
PMID: 42142024 [PubMed - as supplied by publisher]


Association Between Dietary/Supplementary Calcium Intake and Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Cohort Studies.
Nutr Cancer
Karimi M, Rabiee R, Babaeian Amini N, Valizadeh F, Ahmadzadeh M, Asbaghi O, Amirpour M, Davoodi SH, Larijani B.
PMID: 42141946 [PubMed - as supplied by publisher]


Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer.
CA Cancer J Clin
Kaidar-Person O, Weltens CG, Fortpied C, Scheijmans LJEE, Kirkove CY, Budach V, Peignaux-Casasnovas K, Valli M, Peters M, van der Leij F, Rivera S, Weidner N, van den Bongard DHJG, Linsenmeier C, Abdah-Bortnyak R, Hosni S, Koiter E, Engelen AM, Baten A, Champezou L, Fourquet A, Bartelink HGMM, Struikmans H, Poortmans PMP, European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups.
PMID: 42141924 [PubMed - indexed for MEDLINE]


Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese Cohort.
Cancer Med
Zhou L, Ni M, Yang A, Zhou Q, Wang D, Dun S, Xu F, Huang J, Bi X, Xia W, Hong R, Zheng Q, Chen M, Jiang K, Tang J, Wang X, Yuan Z, Wang S, Shi Y, Wang F, An X.
PMID: 42141527 [PubMed - indexed for MEDLINE]


Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer.
Eur Radiol
Bellini C, Bicchierai G, Maiello C, Amato F, de Benedetto D, di Naro F, Vidali S, Tonelli P, Vanzi E, Boeri C, Visani L, Vezzosi V, Orzalesi L, Susini T, Miele V, Nori J.
PMID: 42141291 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 217709    Seite 1 von 10886  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1